Epstein-Barr virus glycoprotein gM can interact with the cellular protein p32 and knockdown of p32 impairs virus

Harish Changotra1, Susan M Turk1, Antonio Artigues2

  • 1Department of Microbiology and Immunology, Center for Molecular and Tumor Virology and Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, LA, USA.

Virology
|January 17, 2016
PubMed

Insights

The Epstein-Barr virus (EBV) gMgN glycoprotein complex

Area of Science:

  • Virology
  • Molecular Biology
  • Cell Biology

Background:

  • The Epstein-Barr virus (EBV) glycoprotein complex gMgN is crucial for enveloped virus assembly and release.
  • Its precise function and interactions within the viral lifecycle remain largely uncharacterized.

Purpose of the Study:

  • To investigate the role of the Epstein-Barr virus (EBV) gMgN glycoprotein complex in viral assembly and release.
  • To identify cellular proteins interacting with the gMgN complex and elucidate their function in EBV pathogenesis.

Main Methods:

  • Analysis of the cytoplasmic tail of EBV gM for complex formation.
  • Investigating the interaction between gM and cellular protein p32 using siRNA and shRNA knockdown.
  • Phenotypic analysis of virus release and nuclear localization in knockdown cells.

Main Results:

  • The cytoplasmic tail of EBV gM is not essential for gMgN complex formation.
  • EBV gM interacts with cellular protein p32, known to be involved in nuclear egress of other herpesviruses.
  • Knockdown of p32 mimics the phenotype of gMgN-deficient EBV, leading to aberrant virus release and nuclear retention.

Conclusions:

  • The cellular protein p32 plays a significant role in the assembly and release of Epstein-Barr virus (EBV).
  • p32 may be involved in the nuclear egress of EBV, similar to its role in human cytomegalovirus and herpes simplex virus.
  • These findings provide new insights into the molecular mechanisms of EBV replication and suggest p32 as a potential therapeutic target.